Size and Shape Filtering of Malignant Cell Clusters within Breast Tumors Identifies Scattered Individual Epithelial Cells as the Most Valuable Histomorphological Clue in the Prognosis of Distant Metastasis Risk.

breast cancer histopathology image analysis individual cell invasion metastasis pan-cytokeratin particle analysis prognosis tumor budding tumor cell dissociation

Journal

Cancers
ISSN: 2072-6694
Titre abrégé: Cancers (Basel)
Pays: Switzerland
ID NLM: 101526829

Informations de publication

Date de publication:
22 10 2019
Historique:
received: 03 08 2019
revised: 08 10 2019
accepted: 18 10 2019
entrez: 27 10 2019
pubmed: 28 10 2019
medline: 28 10 2019
Statut: epublish

Résumé

Survival and life quality of breast cancer patients could be improved by more aggressive chemotherapy for those at high metastasis risk and less intense treatments for low-risk patients. Such personalized treatment cannot be currently achieved due to the insufficient reliability of metastasis risk prognosis. The purpose of this study was therefore, to identify novel histopathological prognostic markers of metastasis risk through exhaustive computational image analysis of 80 size and shape subsets of epithelial clusters in breast tumors. The group of 102 patients had a follow-up median of 12.3 years, without lymph node spread and systemic treatments. Epithelial cells were stained by the AE1/AE3 pan-cytokeratin antibody cocktail. The size and shape subsets of the stained epithelial cell clusters were defined in each image by use of the circularity and size filters and analyzed for prognostic performance. Epithelial areas with the optimal prognostic performance were uniformly small and round and could be recognized as individual epithelial cells scattered in tumor stroma. Their count achieved an area under the receiver operating characteristic curve (AUC) of 0.82, total area (AUC = 0.77), average size (AUC = 0.63), and circularity (AUC = 0.62). In conclusion, by use of computational image analysis as a hypothesis-free discovery tool, this study reveals the histomorphological marker with a high prognostic value that is simple and therefore easy to quantify by visual microscopy.

Identifiants

pubmed: 31652628
pii: cancers11101615
doi: 10.3390/cancers11101615
pmc: PMC6826383
pii:
doi:

Types de publication

Journal Article

Langues

eng

Subventions

Organisme : Instituto Tecnológico de Santo Domingo (INTEC) of Dominican Republic
ID : grant 001-1389016-4
Pays : International

Références

Pathol Int. 2005 Jun;55(6):318-23
pubmed: 15943788
Mod Pathol. 2010 May;23 Suppl 2:S60-4
pubmed: 20436504
PLoS One. 2013 Dec 12;8(12):e82314
pubmed: 24349253
Br J Cancer. 2013 Sep 17;109(6):1618-24
pubmed: 23963148
IEEE Trans Biomed Eng. 2015 Jul;62(7):1862-73
pubmed: 25706507
Methods Mol Biol. 2017;1634:283-303
pubmed: 28819860
Biomark Med. 2016;10(3):219-28
pubmed: 26860337
Anal Cell Pathol (Amst). 2012;35(2):75-8
pubmed: 21971321
Breast Cancer Res Treat. 2015 Apr;150(2):363-71
pubmed: 25779101
Nat Methods. 2012 Jun 28;9(7):676-82
pubmed: 22743772
Acta Oncol. 1992;31(6):629-33
pubmed: 1281649
Hum Pathol. 2008 May;39(5):740-6
pubmed: 18439940
Biotechnol Healthc. 2006 Aug;3(4):12-4
pubmed: 23424367
Breast Cancer Res. 2014;16(2):R35
pubmed: 24708745
Exp Mol Pathol. 2007 Jun;82(3):262-8
pubmed: 17335803
Biomed Microdevices. 2016 Oct;18(5):83
pubmed: 27549346
Radiother Oncol. 2018 Jun;127(3):370-373
pubmed: 29598835
World J Exp Med. 2018 Sep 7;8(2):12-17
pubmed: 30211020
Breast. 2015 Nov;24 Suppl 2:S26-35
pubmed: 26253814
J Transl Med. 2010 Dec 31;8:140
pubmed: 21194459
Br J Cancer. 2011 Oct 11;105(8):1218-23
pubmed: 21934680
Biomark Med. 2016 Oct;10(10):1049-1059
pubmed: 27680104
Sci Transl Med. 2011 Nov 9;3(108):108ra113
pubmed: 22072638
Pathol Oncol Res. 2011 Dec;17(4):809-17
pubmed: 21560015
Br J Cancer. 1982 May;45(5):655-69
pubmed: 7044401
Pathol Res Pract. 2013 May;209(5):269-75
pubmed: 23561623
Breast J. 2015 Mar-Apr;21(2):147-54
pubmed: 25600504
J Natl Cancer Inst. 2006 Sep 6;98(17):1183-92
pubmed: 16954471
J Pathol Inform. 2019 Mar 08;10:9
pubmed: 30984469
Oncologist. 2019 Nov;24(11):e1044-e1054
pubmed: 31300482
Tumour Biol. 2019 Feb;41(2):1010428318823361
pubmed: 30808252
Front Oncol. 2018 Aug 30;8:348
pubmed: 30214894
Histopathology. 2007 Jan;50(1):151-62
pubmed: 17204028
Breast Cancer Res Treat. 2014 Feb;143(3):587-92
pubmed: 24445566
Microsc Microanal. 2015 Jun;21(3):646-54
pubmed: 25857827

Auteurs

Velicko Vranes (V)

Department of Basic and Environmental Science, Instituto Tecnológico de Santo Domingo (INTEC), Santo Domingo 10602, Dominican Republic. velicko.vranes@intec.edu.do.

Nemanja Rajković (N)

Department of Biophysics, School of Medicine, University of Belgrade, 11000 Belgrade, Serbia. nemanja.rajkovic@med.bg.ac.rs.

Xingyu Li (X)

Multimedia Laboratory, The Edward S. Rogers Sr. Department of Electrical & Computer Engineering, University of Toronto, Toronto, ON M5S 3G4, Canada. xingyu.li@mail.utoronto.ca.

Konstantinos N Plataniotis (KN)

Multimedia Laboratory, The Edward S. Rogers Sr. Department of Electrical & Computer Engineering, University of Toronto, Toronto, ON M5S 3G4, Canada. kostas@ece.utoronto.ca.

Nataša Todorović Raković (N)

Department of Experimental Oncology, Institute for Oncology and Radiology, 11000 Belgrade, Serbia. todorovicn@ncrc.ac.rs.

Jelena Milovanović (J)

Department of Experimental Oncology, Institute for Oncology and Radiology, 11000 Belgrade, Serbia. jelena.mil10@gmail.com.

Ksenija Kanjer (K)

Department of Experimental Oncology, Institute for Oncology and Radiology, 11000 Belgrade, Serbia. ksenijakanjer@gmail.com.

Marko Radulovic (M)

Department of Experimental Oncology, Institute for Oncology and Radiology, 11000 Belgrade, Serbia. marko@radulovic.net.

Nebojša T Milošević (NT)

Department of Basic and Environmental Science, Instituto Tecnológico de Santo Domingo (INTEC), Santo Domingo 10602, Dominican Republic. nebojsa.milosevic@med.bg.ac.rs.
Department of Biophysics, School of Medicine, University of Belgrade, 11000 Belgrade, Serbia. nebojsa.milosevic@med.bg.ac.rs.

Classifications MeSH